-
Taiwan reports record COVID-19 complications in a week
Discover the latest on Taiwan’s COVID-19 surge: CDC reports a record high in complications and predicts a peak in mid-July, with a stark warning on vaccination rates.
2024/07/02 17:21
-
XBB疫苗溫度異常退貨!爆供應不足 北榮:1/19停打
新冠疫情開始升溫,疾管署呼籲民眾要儘速接種新冠XBB疫苗,但日前Novavax XBB疫苗有16.5萬劑在運送過程中因溫度異常,要求廠商換貨,希望2月能銜接接種,不過,台北榮總今(15)日就公告,因NOVAVAX XBB.1.5疫苗供應不足,113年1月19日起暫停預約接種服務。
2024/01/15 10:58
-
新冠XBB疫苗今開打!北市加碼「打疫苗抽獎」 最高爽拿萬元
國內新冠疫情升溫,而Novavax XBB.1.5疫苗於今(9)日開打,適用對象為12歲以上民眾,另莫德納XBB.1.5疫苗持續供應滿6個月以上民眾接種。台北市政府衛生局也推出打疫苗抽好禮活動,提供2005個獎項,最高可獲得1萬元等值禮券,總獎額達205萬元,呼籲民眾接種疫苗。
2024/01/09 13:14
-
Taiwan reports 326 new COVID cases, majority unvaccinated
Taiwan’s Centers for Disease Control (CDC) reported 326 new domestic cases of COVID-19 for the week of Dec. 19-25, with 99% of the newly infected individuals not having received the XBB.1.5-adapted vaccine. The CDC also noted a rise in fatalities, with 37 deaths, of which 97% had not been vaccinated with the XBB vaccine. The CDC highlighted that the domestic COVID-19 situation is worsening, with 78% of complications and 90% of deaths affecting people over the age of 65. The global positivity rate for COVID-19 is at its peak, and cases are increasing in neighboring Southeast Asian countries. Since the introduction of the XBB vaccine in Taiwan, almost all domestically reported cases of complications and fatalities have been among unvaccinated individuals. The CDC emphasized the protective role of the vaccine, citing recent Dutch research that found it to be over 70% effective against severe infection in the elderly. The domestic rollout of the XBB vaccine has reached 769,000 doses, with a two-month peak of 68,600 doses administered during the week of Dec. 19-25. The CDC encourages mask-wearing during end-of-year gatherings and New Year’s activities, especially in crowded, poorly ventilated places or when in close contact with vulnerable individuals. Prompt medical attention is advised for those displaying COVID-19 symptoms.
2023/12/26 18:15
-
Taiwan CDC: JN.1 COVID variant sporadically detected locally
Taiwan Centers for Disease Control (CDC) has confirmed that the COVID-19 variant JN.1 has been sporadically detected in Taiwan’s local cases. JN.1 is an offspring of the BA.2.86 variant and was first detected in Taiwan on Oct. 20 through a traveler from Japan. The local proportion of the JN.1 strain is below 5 percent, indicating that it has not become the dominant strain. The World Health Organization (WHO) has recommended the continued use of the XBB.1.5 vaccine strain, which has been shown to be effective against JN.1 and other emerging variants.
2023/12/18 20:10
-
過年疫情將反撲?「JN.1」多國連爆 醫籲快做1事:台灣逃不掉
新冠肺炎(COVID-19)自2019年爆發後,大幅改變人類的生活習慣,儘管世界各國皆已恢復正常生活,但近期卻有許多國家出現新變異株「JN.1」患者。對此,胸腔暨重症專科醫師黃軒就直言,隨著農曆春節將至,台灣勢必「逃不掉」這波疫情,同時也呼籲民眾應儘速接種XBB.1.5疫苗。
2023/12/17 10:17
-
「這款」XBB.1.5 疫苗可專案輸入 最快一月中開打
冬天是不少呼吸道疾病爆發的季節,雖然現在民眾生活已經回歸正常,不過上週還是有新增232例新冠本土病例,其中34人死亡。食藥署已經確定,核准Novavax XBB.1.5 疫苗專案輸入,疾管署副署長羅一鈞指出,最快一月中旬可以開打。
2023/12/14 10:31
-
CDC urges vaccinations amid death spike, new wave fears
Taiwan’s CDC is urging high-risk groups, including seniors aged 65 and older and those with chronic illnesses, to get vaccinated promptly in anticipation of a potential new wave of COVID-19 infections by mid to late January. The urgency for vaccinations is emphasized due to the high international positivity rate for COVID-19 and fluctuating domestic cases. While there has been a slight decline in complications from new domestic cases, there has been a concerning increase in deaths, marking the highest in nearly five weeks. The CDC highlights the effectiveness of the XBB.1.5-adapted COVID-19 vaccine, which can reduce the risk of severe illness and death by 50 percent and 61 percent, respectively. Approximately 649,000 doses of the XBB vaccine have been administered nationally, with 43,400 doses given in the last week alone. The CDC also clarifies that mRNA vaccines are safe and effective, designed to enhance mRNA technology without negatively affecting biosystems.
2023/12/12 20:29
-
Taiwan reports highest weekly COVID-19 deaths in a month
Taiwan is experiencing a surge in COVID-19 complications and deaths, with the CDC reporting the highest weekly count in a month. Authorities are encouraging vaccinations, especially for high-risk groups, as the country braces for a peak in infections.
2023/12/06 17:42
-
公費流感疫苗第2階段今開打 QA一次看懂
今(1)日公費流感疫苗第二階段開打,疾管署再度與超市全聯、各縣市衛生局合作,於全聯指定門市設置接種站,據點眾多方便民眾就近施打;疾管署長莊人祥指出,截至10月30日已經有380萬人接種流感疫苗,新冠XBB.1.5疫苗已於10月11日開放全民施打,提醒民眾在疫後的新生活,擁有雙重保護力,針對第二階段流感疫苗接種對象等內容,《TVBS新聞網》也整理QA讓民眾一次懂。
2023/11/01 10:57
-
注意! COVID-19、流感、RSV年底恐合併流行
最近天氣變化較大,溫度明顯變涼,但觀眾朋友就要小心,尤其是家中有長輩、小朋友的更要注意。有醫師提到,今年年底可能會有新冠、流感及RSV,這三種病毒合併流行,其中新冠的情況,疾管署預估,到年底可能平均一天的病例數,會來到2.2萬到2.4萬之間;昨天公費疫苗XBB.1.5也已經開放全民施打,民眾也要注意保暖,留意身體狀況。
2023/10/12 13:43
-
Taiwan prioritizes elderly for Moderna XBB.1.5 vaccines
Taiwan prioritizes 65+ for Moderna vaccine, offers test kits and vouchers. Hospitals see a 30% increase in patients. Doctors urge prompt antiviral medication for flu. Elderly advised to get COVID and flu vaccines, with pneumococcal vaccine later.
2023/09/26 18:55
-
今起開打XBB.1.5疫苗 逾65歲可獲500元禮券
為了降低感染新冠病毒後併發重症和死亡風險,今天起優先開放65歲以上民眾接種「莫德納XBB.1.5疫苗」,上午有不少長輩到診所或衛生所打疫苗,不過多數不知道政府為了鼓勵接種,還發給長輩五百元禮券以及快篩試劑!
2023/09/26 15:06
-
南投打疫苗送500禮券 9/26起開放65歲以上接種
為降低民眾感染武漢肺炎新型冠狀病毒病,COVID-19後併發重症和死亡風險,南投縣衛生局宣布,26日起全縣13鄉鎮市衛生所開放65歲以上長者含55歲以上原住民接種,且無論接種XBB.1.5或Novavax疫苗,皆可領取禮券500元或等值宣導品,送完為止。
2023/09/25 18:15
-
XBB.1.5疫苗9/26起長者優先打 10/9全民接種
可別以為新冠疫情已經完全消失,目前主流株已轉換為XBB病毒,也因此疾管署規劃得再打疫苗,9月26日開始,65歲以上長者,優先能接種莫德納XBB.1.5新型疫苗,並且考量10月2日公費流感疫苗,也要開打,避免混亂,一般民眾暫定再延一個禮拜,10月9日能接種,而滿5歲以上,不論先前打過幾劑疫苗或沒打過,通通都只需要接種1劑即可。
2023/09/20 20:38
-
莫德納XBB疫苗9/26起三階段接種 65歲以上優先
衛生福利部疾病管制署長莊人祥今天表示,莫德納XBB.1.5疫苗首波9月26日由65歲以上長者開打,10月2日開放醫護人員接種,並暫定10月9日開始全民接種,將視接種情形調整。
2023/09/20 15:11
-
莫德納XBB疫苗拚中秋前開打 首批70萬劑近期到貨
衛生福利部疾病管制署發言人曾淑慧今天表示,莫德納XBB.1.5疫苗預計近期到貨,首批估有70萬劑,將盡力趕在中秋連假前開打,由65歲以上民眾優先接種。
2023/09/19 16:30
-
新冠新疫苗開打 譚德塞要求二訪中國找起源
新冠疫情在歐美有穩步上升的趨勢,同時今年針對XBB.1.5新冠病毒變異株更新配方的2023年版新冠疫苗,也已經開打,不再是過去疫苗的「加強針」,主要用於預防重症、降低死亡率,在流感疫情同時燒起的現在,疫苗已經不能完全預防感染。世衛組織秘書長譚德塞最近接受英國金融時報訪問,頗富深意地指出,世衛專家團準備好第二次進入中國,探求疫情起源的答案,希望能夠得到足夠權限,他也表示找到疫情起源只是時間問題。
2023/09/18 19:51
-
新冠變異株致快篩準確度下降? 食藥署:應不影響檢測性能
有媒體報導指出,醫師認為新冠快篩準確率下降到只剩下7成,近期國內快篩出現「測不準」的偽陰性現象,導致民眾延誤病情。對此食藥署表示,國內核准的快篩評估應該不會影響檢測目前的XBB.1.5變異株,不過快篩試劑本來靈敏度就不如核酸檢測,應該搭配臨床症狀判斷。
2023/06/22 14:27
-
首見本土XBB.1.5 解禁如期新冠4月將降級
本土首度驗出XBB.1.5個案,但上周疫情來到今年最低點,指揮中心表示,20日實施輕症免隔離新制後,觀察2週,有可能提前至4月將COVID-19由第五類傳染病改為第四類,指揮中心也可能同時降級開設,也將會鬆綁大眾運輸口罩令。
2023/03/16 17:32
-
XBB.1.5入侵!國內首度檢出2本土 兩女重複感染
國內疫情趨緩,不過席捲全球傳染力高的XBB.1.5病毒株,也在國內首度檢出2例本土個案,兩例都是重複感染的個案,分別為中部一名10多歲的青少女,以及北部一位50多歲的女性。
2023/03/16 14:12
-
大陸推「15分鐘便民圈」 小攤經濟助內需
大陸國家衛健委監測2月10號到17號一周的疫情數據,發現14例本土重點關注變異株,其中包括出現本土的XBB.1.5病例;但專家認為,免疫屏障形成,不至於重現大流行。大陸全力拚經濟,不少活動復辦;商務部宣布要推15分鐘便民生活圈,過去因為市容被迫消失的小攤販,能重啟爐灶。
2023/02/20 20:00
-
BA.2.75連三週成主流病毒 30多歲男入境再驗出XBB.1.5
中央流行疫情指揮中心今(13)日公布國內新增82例Omicron亞型變異株確定病例,分別為55例本土個案( 33例BA.2.75、14例BA.5、8例BQ.1)及27例境外移入( 10例BA.2.75、5例BA.5、5例XBB、4例BQ.1、2例BF.7、1例BA.2)。
2023/02/13 14:10
-
首例XBB.1.5入侵台!20歲男加拿大入境 機場自曝2症狀
日前在美國迅速傳播的變異株XBB.1.5入侵台灣!指揮中心今(6)日公布最新境外移入病毒基因定序結果,一名20多歲本國籍男性從加拿大入境,主動表示有流鼻水、肌肉痠痛等症狀採檢確診,定序為台灣首例XBB.1.5境外個案。
2023/02/06 14:08
-
新變種CH.1.1有Delta突變! 二價疫苗也難防
農曆新年假期剛結束,不少國家的疫情出現明顯升溫。如今又傳出,繼早前的新變種病毒XBB.1.5後,英美國家境內又出現新變種「CH.1.1」病毒株。雖然目前對於「CH.1.1」的了解還不多,不過研究顯示,這款新變種病毒株除了有高度傳染性外,也具備疫苗免疫逃脫力,還可能會導致患者出現更嚴重的症狀。
2023/01/30 10:17